446 related articles for article (PubMed ID: 9630355)
1. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
3. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
4. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
5. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
6. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
7. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
[TBL] [Abstract][Full Text] [Related]
8. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
10. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
13. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
14. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
15. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
Waldo GL; Harden TK
Mol Pharmacol; 2004 Feb; 65(2):426-36. PubMed ID: 14742685
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
17. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
18. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
Léon C; Hechler B; Vial C; Leray C; Cazenave JP; Gachet C
FEBS Lett; 1997 Feb; 403(1):26-30. PubMed ID: 9038354
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]